ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5055	Burn wound healing	40/592	91/5488	3.23301324957081e-16	9.62520038023131e-14	7.87311060266993e-14	8038/6347/57124/1277/1278/2919/3579/7852/2162/2200/3082/3383/3552/3553/3569/3624/3791/3956/23643/440823/4312/4322/4313/4314/4318/100463486/64332/64127/5159/6282/6280/6423/6678/7043/7076/7097/51311/3371/7124/7128	40
WP5095	Overview of proinflammatory and profibrotic mediators	31/592	57/5488	4.08713391941881e-16	9.62520038023131e-14	7.87311060266993e-14	6356/6357/6362/6347/6364/6369/6370/6348/6351/1440/2919/3627/6373/2920/2921/6374/6372/4283/3589/3552/3553/3557/11009/3569/4312/4314/4318/5008/6696/7124/10673	31
WP5115	Network map of SARS-CoV-2 signaling pathway	55/592	180/5488	1.35943632515867e-13	2.1343150304991e-11	1.74580243862481e-11	59272/183/335/341/8542/684/715/838/6356/6347/6364/6348/6351/1234/9332/1051/629/3426/5199/1294/2919/3627/2920/2921/6374/6372/4283/3577/3579/1843/84985/3091/3429/10964/8519/10410/8807/3552/3553/3569/10379/3699/3726/116844/64386/114548/4939/5743/6288/6289/6403/5054/6772/7124/7535	55
WP2806	Complement system	32/592	73/5488	3.61613482204259e-13	4.25799875295515e-11	3.48290880228313e-11	133/335/409/715/717/720/722/728/958/1604/22918/629/3426/5199/2162/2214/2219/2357/2769/3383/3687/3689/5648/5329/5806/6401/6402/6403/6404/710/6696/7097	32
WP619	Type II interferon signaling	19/592	33/5488	6.14115841277746e-11	5.78497122483637e-09	4.73192416647695e-09	4261/3627/4283/1536/2633/3106/3383/3433/3553/3659/10379/9636/4843/5698/8651/9021/6688/6772/6890	19
WP4754	IL-18 signaling pathway	56/592	228/5488	1.18176795569266e-09	9.27687845218734e-08	7.58819424181599e-08	321/467/330/6362/6347/6364/6348/6351/9308/1051/9076/24146/1277/1278/1281/2920/2921/338442/26353/3383/8870/8809/8807/3553/3559/3569/3659/3801/10365/4312/4322/4313/4314/4318/653361/4688/64332/4843/8431/7941/5743/5806/6004/8698/9021/6696/30009/7052/7076/7124/7127/7128/4982/79931/7185/80149	56
WP3624	Lung fibrosis	21/592	48/5488	4.67917597655881e-09	2.80898227967742e-07	2.29765898840527e-07	6356/6347/6348/6351/1051/1215/1440/2920/57105/2252/26585/3082/3553/3569/4313/4318/5328/5806/6696/7076/7124	21
WP2328	Allograft rejection	26/592	70/5488	4.77109516718033e-09	2.80898227967742e-07	2.29765898840527e-07	5243/717/720/721/958/1604/941/1493/6373/4283/50943/10578/3002/3106/3107/3108/3119/3133/3134/3552/3553/3559/120892/5551/6772/7124	26
WP2882	Nuclear receptors meta-pathway	58/592	250/5488	5.95647611609422e-09	3.11722250075597e-07	2.54978977601226e-07	5243/1244/64240/64241/51129/335/345/8553/330/874/6347/6364/1545/1555/1557/1559/1576/1551/1907/9982/4616/2938/2939/1839/3082/3589/3553/3726/23764/4199/8431/9971/5142/5743/6286/6319/5272/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/6533/23657/8140/5552/27286/2040/6822/7056/7124/7128/7364	58
WP2877	Vitamin D receptor pathway	37/592	127/5488	6.95847022610162e-09	3.27743947649386e-07	2.68084221342441e-07	5243/240/248/604/768/838/875/958/634/1493/1594/1555/1559/1565/1576/1673/11221/50486/3091/3488/9173/3684/3726/126364/4600/639/6279/6280/10568/6696/79689/412/6822/7056/7128/4982/54210	37
WP4891	COVID-19 adverse outcome pathway	10/592	12/5488	1.07349847523102e-08	4.59652528939829e-07	3.75981284147899e-07	59272/183/6347/6348/1440/3627/3553/3559/3569/7124	10
WP129	Matrix metalloproteinases	13/592	21/5488	2.11987343849015e-08	8.32050324607386e-07	6.80590946041576e-07	4312/4319/4321/4322/4327/4313/10893/64386/4314/4316/4318/7076/7124	13
WP5088	Prostaglandin signaling	14/592	26/5488	7.01254321924966e-08	2.5406983509743e-06	2.07821118886265e-06	834/6347/6348/2919/3627/4283/3552/3553/3569/3665/4318/114548/9536/7124	14
WP691	Tamoxifen metabolism	10/592	14/5488	1.32934414306027e-07	4.47229350986704e-06	3.65819516060193e-06	1545/1557/1558/1559/1565/1576/2326/6783/6822/7364	10
WP1533	Vitamin B12 metabolism	16/592	35/5488	1.57322112274421e-07	4.93991432541682e-06	4.04069425210092e-06	335/338/348/875/6347/8029/3383/3553/3569/3949/6288/6289/5054/6648/6947/7124	16
WP455	GPCRs, class A rhodopsin-like	27/592	88/5488	2.48662005997987e-07	7.31998780156574e-06	5.98751935495153e-06	51554/150/1230/1234/10803/3577/3579/7852/57105/1909/2151/2867/2357/2358/29909/8477/8111/8843/3352/4888/53829/5031/5724/5737/266747/6752/56670	27
WP24	Peptide GPCRs	13/592	27/5488	1.12719096995084e-06	2.9166010938075e-05	2.38568778709028e-05	728/1230/1234/10803/3577/3579/7852/10663/1909/2357/2358/4888/6752	13
WP5198	Inflammatory bowel disease signaling	14/592	31/5488	1.14935798033743e-06	2.9166010938075e-05	2.38568778709028e-05	50943/3108/3594/3595/8807/3552/50615/3569/64127/6772/6775/30009/7097/7124	14
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	20/592	58/5488	1.17654821193933e-06	2.9166010938075e-05	2.38568778709028e-05	59272/6347/6348/6351/2919/3627/6373/2920/2921/6374/6372/4283/3579/3433/8519/3569/3665/3902/6772/7124	20
WP3617	Photodynamic therapy-induced NF-kB survival signaling	14/592	32/5488	1.84320784380818e-06	4.34075447216827e-05	3.55060037280945e-05	597/330/2920/3383/3552/3553/3569/4312/4313/4314/4318/5743/6401/7124	14
WP15	Selenium micronutrient network	19/592	55/5488	2.11415975071138e-06	4.74175829802409e-05	3.87860886596674e-05	240/335/338/875/6347/1734/3383/3553/3569/8564/8942/3949/5743/6288/6289/5054/6648/7124/7498	19
WP2865	IL1 and megakaryocytes in obesity	11/592	21/5488	2.69275334243753e-06	5.76494011040035e-05	4.71553934608677e-05	6347/2205/1839/3383/3553/4318/114548/7941/6280/7076/7097	11
WP430	Statin inhibition of cholesterol production	11/592	22/5488	4.86516515146846e-06	9.96301211452889e-05	8.1494299562355e-05	64240/64241/335/337/338/341/345/348/3949/4547/6713	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	9/592	15/5488	5.13112867822244e-06	0.000100698400310115	8.23681182556761e-05	6347/958/3383/3553/6401/6403/6404/7043/7097	9
WP5218	Extrafollicular B cell activation by SARS-CoV-2	19/592	62/5488	1.55677776461467e-05	0.000293296930853404	0.000239907647094303	604/720/958/941/7852/83416/29851/3433/8519/3569/9636/3687/3689/639/6402/57823/30009/7124/10673	19
WP2431	Spinal cord injury	23/592	87/5488	3.02771086623953e-05	0.000548481468461084	0.000448640557507558	199/301/6347/50515/1282/2919/3627/2920/2212/3383/3552/3553/3569/10288/4321/4318/4843/5320/5743/6403/7124/10673/7538	23
WP2880	Glucocorticoid receptor pathway	18/592	60/5488	3.58876052472046e-05	0.000626039335979013	0.000512080449141399	51129/8553/330/6347/6364/1907/9982/4616/3589/8972/5142/5743/6286/5272/5552/2040/7056/7128	18
WP530	Cytokines and inflammatory response	8/592	16/5488	0.000102370768985282	0.00169757884245407	0.00138856599919139	1440/2919/2920/3589/3552/3553/3569/7124	8
WP4494	Selective expression of chemokine receptors during T-cell polarization	9/592	20/5488	0.00010452183955662	0.00169757884245407	0.00138856599919139	6348/6351/1230/1234/7852/3594/3595/8809/7043	9
WP43	Oxidation by cytochrome P450	12/592	34/5488	0.00012981542948832	0.00203810224296662	0.00166710341027106	1545/1594/1555/1557/1558/1559/1565/1576/1551/8529/260293/9420	12
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	7/592	13/5488	0.000157256295677864	0.00238928113755723	0.00195435667973169	335/338/348/3949/9388/4547/255738	7
WP558	Complement and coagulation cascades	14/592	45/5488	0.000171677623137755	0.00252688001555883	0.00206690822593481	715/717/721/728/1604/629/3426/5648/5328/5329/5054/710/7056/7450	14
WP4329	miRNAs involvement in the immune response in sepsis	12/592	36/5488	0.000241899147879099	0.00331944761288893	0.00271520354523936	6348/6351/3002/3383/3552/3569/3659/3665/3934/114614/51311/7124	12
WP702	Metapathway biotransformation Phase I and II	24/592	105/5488	0.000248100078788186	0.00331944761288893	0.00271520354523936	50515/9435/9469/1545/1594/1555/1557/1558/1559/1565/1576/1551/8529/260293/9420/2326/2938/2939/9027/4837/6783/6822/79799/7364	24
WP2911	miRNA targets in ECM and membrane receptors	9/592	22/5488	0.00025371574111253	0.00331944761288893	0.00271520354523936	1278/1281/1282/1284/1290/50509/1291/1293/7058	9
WP4969	RAS and bradykinin pathways in COVID-19	9/592	22/5488	0.00025371574111253	0.00331944761288893	0.00271520354523936	1636/59272/183/1576/3552/3553/5054/710/7124	9
WP545	Complement activation	8/592	18/5488	0.000285868292864653	0.00363902610646626	0.00297660868245983	715/717/720/721/1604/629/5199/5648	8
WP2876	Pregnane X receptor pathway	10/592	27/5488	0.000302503442177858	0.00365331080168644	0.00298829311301204	5243/1244/1555/1557/1559/1576/1551/2939/27286/6822	10
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	10/592	27/5488	0.000302503442177858	0.00365331080168644	0.00298829311301204	59272/6347/2939/3553/3569/4312/4314/5593/23657/7124	10
WP3937	Microglia pathogen phagocytosis pathway	12/592	37/5488	0.000323508280010218	0.00380930999712031	0.00311589553904578	1536/2207/2209/3055/3684/3689/4067/653361/4688/8503/54210/7305	12
WP5094	Orexin receptor pathway	23/592	101/5488	0.000352068479718058	0.00404449399871233	0.00330826864125313	8553/2920/1734/1846/1959/1960/4616/1839/3091/3383/3553/3569/3726/3949/23764/4322/4314/8013/5069/6401/6696/3371/7124	23
WP299	Nuclear receptors in lipid metabolism and toxicity	9/592	23/5488	0.00037743020913446	0.00423261020243645	0.00346214176800031	5243/1244/64240/1594/1555/1559/1576/9971/5915	9
WP2289	Drug induction of bile acid pathway	6/592	11/5488	0.000440994271541998	0.0048304256254949	0.00395113594576184	5243/1244/1576/9971/200931/6822	6
WP75	Toll-like receptor signaling pathway	20/592	84/5488	0.000456966295080438	0.00489161647688378	0.0040011881339579	6348/6351/958/941/3627/6373/4283/3553/3569/3665/23643/1326/5600/6300/8503/6696/6772/7097/51311/7124	20
WP453	Inflammatory response pathway	9/592	24/5488	0.000546889224155018	0.00572410721282252	0.00468213932259033	958/941/1277/1278/1281/3559/3918/7133/7535	9
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	11/592	34/5488	0.000586636492140928	0.00600664756083429	0.00491324842388054	84674/834/838/50506/3553/4210/58484/114548/64127/639/8767	11
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	16/592	62/5488	0.000651479997055816	0.00650808861312384	0.00532341140329271	6347/958/1594/1673/10964/3569/9636/5600/6300/64127/4939/91543/6772/7097/51311/7124	16
WP4538	Regulatory circuits of the STAT3 signaling pathway	17/592	68/5488	0.000663244699426633	0.00650808861312384	0.00532341140329271	1271/1439/1441/1844/2151/3595/3601/50615/3559/3563/3575/3718/5600/6300/9180/5159/9021	17
WP4136	Fibrin complement receptor 3 signaling pathway	11/592	35/5488	0.000773708514367494	0.00738416223394382	0.00604001201837845	6347/3627/2921/3569/3656/3684/3689/23643/4843/7124/7305	11
WP4493	Cells and molecules involved in local acute inflammatory response 	7/592	16/5488	0.000783881341182996	0.00738416223394382	0.00604001201837845	3383/3552/3569/3689/6403/6404/7124	7
WP697	Estrogen metabolism	6/592	12/5488	0.00080199546945835	0.00740666404146829	0.00605841778785875	1545/1576/2938/412/6783/7364	6
WP176	Folate metabolism	13/592	46/5488	0.000821293374235852	0.00743902267817474	0.00608488613300247	335/338/875/6347/3383/3553/3569/3949/6288/6289/5054/6648/7124	13
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	9/592	26/5488	0.00107224285354243	0.00952879969846199	0.00779425788275134	6347/29126/941/1493/3627/3559/8651/7043/51311	9
WP167	Eicosanoid synthesis	7/592	17/5488	0.00120993753936121	0.0105174641999656	0.00860295429028365	246/240/1800/5320/5730/9536/5743	7
WP5090	Complement system in neuronal development and plasticity	19/592	84/5488	0.00122815399362656	0.0105174641999656	0.00860295429028365	715/717/720/721/722/725/728/843/1604/629/3426/5199/2219/3684/3687/3689/5648/710/7043	19
WP5092	Interactions of natural killer cells in pancreatic cancer	8/592	22/5488	0.00141163232023558	0.0118728361219814	0.00971160581214706	6347/6348/6351/2214/3002/4277/5551/7124	8
WP117	GPCRs, other	9/592	27/5488	0.00145711255922471	0.0120403511472779	0.00984862782412272	1234/3577/3579/1909/29933/11245/53829/5737/6752	9
WP2875	Constitutive androstane receptor pathway	8/592	24/5488	0.00267136555715678	0.0216933306451869	0.0177444608696802	5243/1244/1555/1557/1559/1576/2939/6822	8
WP497	Urea cycle and metabolism of amino groups	6/592	15/5488	0.00327042092782032	0.0259843589024123	0.0212543867656339	384/445/1373/2628/4942/5009	6
WP4496	Signal transduction through IL1R	9/592	30/5488	0.00331010941432004	0.0259843589024123	0.0212543867656339	3552/3553/3556/3557/3569/3656/11213/7043/7124	9
WP2848	Pluripotent stem cell differentiation pathway	8/592	26/5488	0.00467182903922164	0.0356041959394775	0.0291231103226031	3577/3082/3589/3569/3624/6469/7043/7474	8
WP4478	LTF danger signal response pathway	6/592	16/5488	0.00476234467980273	0.0356041959394775	0.0291231103226031	3552/3553/3569/7097/7124/54210	6
WP5033	Genes associated with the development of rheumatoid arthritis	6/592	16/5488	0.00476234467980273	0.0356041959394775	0.0291231103226031	958/4261/1493/3559/6775/7185	6
WP465	Tryptophan metabolism	9/592	32/5488	0.00533279725556929	0.0392460548027053	0.0321020361108283	8854/316/1545/1576/9420/3620/8942/4129/6999	9
WP4724	Omega-9 fatty acid synthesis	5/592	12/5488	0.00595739831534097	0.0425141607049333	0.0347752437546219	2180/2182/3992/9415/6319	5
WP5109	Familial hyperlipidemia type 2	5/592	12/5488	0.00595739831534097	0.0425141607049333	0.0347752437546219	335/337/338/3949/255738	5
WP2884	NRF2 pathway	21/592	110/5488	0.00622253959489951	0.0437435246148906	0.0357808246933734	1244/874/2938/2939/1839/3082/23764/4199/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/6533/23657/7364	21
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	39/592	244/5488	0.00704370577006548	0.0486802364569363	0.0398188994149932	285/1277/1278/1281/1282/1284/1290/50509/84699/9586/1440/1441/2252/2254/2786/3082/3091/3559/3563/3575/3678/3687/3689/3718/3791/3918/10319/4843/5008/9180/5159/5209/5228/6514/6515/6696/7058/3371/7450	39
WP2374	Oncostatin M signaling pathway	14/592	64/5488	0.00713149960834099	0.0486802364569363	0.0398188994149932	6347/1051/3091/3718/3726/3949/4312/4322/4314/5008/9180/5054/9021/6772	14
WP3929	Chemokine signaling pathway	25/592	140/5488	0.00732300411016447	0.0492733562269638	0.0403040526965443	409/6356/6364/6369/6370/6348/6351/1230/10803/3627/6373/2921/6374/4283/3579/7852/10663/2268/2786/3055/3718/4067/653361/8503/6772	25
WP4197	Immune response to tuberculosis	7/592	23/5488	0.00857874134350924	0.0569096784900402	0.0465503236727114	3437/8519/3659/10379/8651/6772/6890	7
WP4210	Tryptophan catabolism leading to NAD+ production	5/592	13/5488	0.00883412910806377	0.0569982850670964	0.0466228010605817	3620/8564/8942/10135/6999	5
WP5174	Ulcerative colitis signaling	5/592	13/5488	0.00883412910806377	0.0569982850670964	0.0466228010605817	50943/3108/64127/7097/7124	5
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	9/592	35/5488	0.0100113815289339	0.0637210905422685	0.0521218440908935	285/597/664/3091/4843/5743/5054/6515/7043	9
WP5097	CCL18 signaling pathway	8/592	30/5488	0.011887818472163	0.0745109302661275	0.0609475929766514	467/960/1278/3091/440823/4313/4318/6772	8
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	6/592	19/5488	0.0121811924214264	0.0745109302661275	0.0609475929766514	2919/2920/3553/6469/55553/7124	6
WP727	Monoamine transport	6/592	19/5488	0.0121811924214264	0.0745109302661275	0.0609475929766514	183/3553/6532/6999/7124/4982	6
WP5063	FOXP3 in COVID-19	5/592	14/5488	0.012543900421971	0.0757458602403632	0.0619577267805854	941/50943/3559/3569/3575	5
WP2879	Farnesoid X receptor pathway	4/592	10/5488	0.0165420615356257	0.0961890244849349	0.0786795909296819	1576/8431/9971/6822	4
WP5108	Familial  hyperlipidemia type 1	4/592	10/5488	0.0165420615356257	0.0961890244849349	0.0786795909296819	51129/335/337/3949	4
WP5110	Familial hyperlipidemia type 3	4/592	10/5488	0.0165420615356257	0.0961890244849349	0.0786795909296819	335/337/348/3949	4
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	5/592	15/5488	0.0171806401690463	0.0970581199142094	0.0793904836039795	249/1594/5251/142680/6696	5
WP516	Hypertrophy model	5/592	15/5488	0.0171806401690463	0.0970581199142094	0.0793904836039795	467/11072/1839/3552/8013	5
WP5122	Prostaglandin and leukotriene metabolism in senescence 	7/592	26/5488	0.0173097283923431	0.0970581199142094	0.0793904836039795	246/240/3488/5600/5730/9536/5743	7
WP4747	Netrin-UNC5B signaling pathway	10/592	45/5488	0.0192401216319876	0.106612909278426	0.0872060002143341	249/6347/1003/1277/3383/3552/3791/54538/6401/7124	10
WP3287	Overview of nanoparticle effects	5/592	16/5488	0.0228253199368844	0.123571559658305	0.101077641825767	1001/1282/3569/5743/7124	5
WP3967	miR-509-3p alteration of YAP1/ECM axis	5/592	16/5488	0.0228253199368844	0.123571559658305	0.101077641825767	1277/1281/1909/6678/7058	5
WP4707	Aspirin and miRNAs	4/592	11/5488	0.0238179173867129	0.124647100990464	0.101957400743122	283120/114614/4597/5743	4
WP4723	Omega-3 / omega-6 fatty acid synthesis	4/592	11/5488	0.0238179173867129	0.124647100990464	0.101957400743122	2180/2182/3992/9415	4
WP554	ACE inhibitor pathway	4/592	11/5488	0.0238179173867129	0.124647100990464	0.101957400743122	1636/59272/183/1215	4
WP3945	TYROBP causal network in microglia	12/592	60/5488	0.0243688123465306	0.126128688079296	0.103169292294161	10261/3684/3687/3689/4688/375387/5341/170954/64092/6696/7133/7305	12
WP4298	Acute viral myocarditis	14/592	74/5488	0.0248696392041896	0.12732173983884	0.104145171038139	199/834/1234/1604/941/7852/3108/3569/3689/4318/64127/8651/6772/7124	14
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	6/592	22/5488	0.0253458181135725	0.128364304639706	0.104997956192049	246/240/8529/57105/1800/2358	6
WP716	Vitamin A and carotenoid metabolism	7/592	28/5488	0.0257932295068424	0.129240543592795	0.105714692043721	64240/64241/8854/9227/29881/5915/5948	7
WP3942	PPAR signaling pathway	10/592	48/5488	0.0294308432670512	0.145915022934538	0.119353890700729	2180/2182/51129/335/345/2172/9415/4199/4312/6319	10
WP5036	Angiotensin II receptor type 1 pathway	6/592	23/5488	0.0312636099147713	0.15180577597791	0.124172341061382	59272/183/1277/1278/3091/3589	6
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	6/592	23/5488	0.0312636099147713	0.15180577597791	0.124172341061382	1636/59272/183/3569/114548/7124	6
WP364	IL6 signaling pathway	9/592	42/5488	0.032062653608882	0.154097039283504	0.126046522243295	183/3055/3569/3659/3726/639/9021/6772/7076	9
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	8/592	36/5488	0.0345910389765453	0.16456948846417	0.134612655666301	684/3429/8519/10581/10410/3726/5600/6300	8
WP2849	Hematopoietic stem cell differentiation	9/592	43/5488	0.0368260901727323	0.170967123184879	0.13984571926621	4261/1440/7852/3552/3553/3569/399/6688/23650	9
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	9/592	43/5488	0.0368260901727323	0.170967123184879	0.13984571926621	2180/2182/9023/3992/9415/4597/6319/8435/6713	9
WP5044	Kynurenine pathway and links to cell senescence	5/592	18/5488	0.0373877148366083	0.170967123184879	0.13984571926621	3620/8564/8942/6999/7124	5
WP5066	FOXA2 pathway	5/592	18/5488	0.0373877148366083	0.170967123184879	0.13984571926621	1244/338/2938/2939/4547	5
WP5130	Th17 cell differentiation pathway	11/592	58/5488	0.0431404896345489	0.194575225456356	0.159156402988102	50943/3091/3108/3553/50615/3559/3569/9021/6772/30009/7535	11
WP5111	Familial hyperlipidemia type 4	4/592	13/5488	0.043376642617659	0.194575225456356	0.159156402988102	335/337/3949/4547	4
WP12	Osteoclast signaling	4/592	14/5488	0.0557097394959343	0.247540446250802	0.202480284563177	1513/8111/6696/4982	4
WP474	Endochondral ossification	10/592	54/5488	0.0601903217765357	0.259655291110413	0.21238984589655	9507/249/50515/4256/4322/4318/5328/55553/6696/6772	10
WP4808	Endochondral ossification with skeletal dysplasias	10/592	54/5488	0.0601903217765357	0.259655291110413	0.21238984589655	9507/249/50515/4256/4322/4318/5328/55553/6696/6772	10
WP3611	Photodynamic therapy-induced AP-1 survival signaling	9/592	47/5488	0.0606413631043428	0.259655291110413	0.21238984589655	602/2252/1839/3569/3726/5600/6300/4313/7124	9
WP3646	Hepatitis C and hepatocellular carcinoma	9/592	47/5488	0.0606413631043428	0.259655291110413	0.21238984589655	330/960/1284/3577/3091/3569/4312/4843/5743	9
WP4595	Urea cycle and associated pathways	5/592	21/5488	0.0679269742039392	0.288230674324823	0.235763608901297	445/1373/4843/4942/5009	5
WP5149	Lipid metabolism in senescent cells	4/592	15/5488	0.0697203210693479	0.293198850211275	0.239827420219749	240/84647/7941/5743	4
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/592	22/5488	0.0804508436422824	0.335330507570929	0.27428978829134	285/2022/2200/4053/5054	5
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	3/592	10/5488	0.0842112268195909	0.344070715584253	0.281439003025671	1116/4318/9021	3
WP5188	Retinol metabolism	3/592	10/5488	0.0842112268195909	0.344070715584253	0.281439003025671	316/1551/9227	3
WP3413	NOTCH1 regulation of endothelial cell calcification	4/592	16/5488	0.0853519881135025	0.344070715584253	0.281439003025671	249/2702/4256/55553	4
WP5222	2q13 copy number variation syndrome	8/592	43/5488	0.0855478430424943	0.344070715584253	0.281439003025671	3552/3553/3556/3557/3569/8651/9021/6772	8
WP4331	Neovascularisation processes	7/592	36/5488	0.0862003066644201	0.344070715584253	0.281439003025671	7852/3091/3791/4318/4854/4855/7043	7
WP4172	PI3K-Akt signaling pathway	35/592	259/5488	0.0918337508322682	0.363476442369734	0.297312276024858	285/1277/1278/1282/1284/1291/1293/256076/84699/9586/1440/1441/2252/2254/2786/3082/3559/3563/3569/3575/3678/3718/3791/3918/10319/5008/9180/5159/5228/8503/6696/7058/7097/3371/7450	35
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	5/592	23/5488	0.0941139641221466	0.369397309179425	0.302155358497418	8529/5730/9536/5737/5743	5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	8/592	44/5488	0.0952136502335937	0.370625035206799	0.303159599699829	6356/3055/3559/3569/3575/4067/6772/6775	8
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	6/592	30/5488	0.0970361195102314	0.372959929087167	0.305069469317026	59272/3665/10379/4939/6772/7097	6
WP4239	Epithelial to mesenchymal transition in colorectal cancer	18/592	121/5488	0.0973971789335915	0.372959929087167	0.305069469317026	9076/24146/51208/1282/1284/3091/3678/5600/6300/4313/4318/4854/4855/8828/8503/6678/7043/7474	18
WP3971	OSX and miRNAs in tooth development	3/592	11/5488	0.10685871785692	0.396302804020547	0.324163205434172	249/4854/4855	3
WP4211	Transcriptional cascade regulating adipogenesis	3/592	11/5488	0.10685871785692	0.396302804020547	0.324163205434172	1051/1959/10365	3
WP4495	IL-10 anti-inflammatory signaling pathway 	3/592	11/5488	0.10685871785692	0.396302804020547	0.324163205434172	3552/3569/6772	3
WP4842	Mammalian disorder of sexual development	3/592	11/5488	0.10685871785692	0.396302804020547	0.324163205434172	2254/5600/5730	3
WP2406	Cardiac progenitor differentiation	5/592	24/5488	0.108877002973381	0.400633346878611	0.327705453028432	290/7852/3624/3791/7070	5
WP4756	Renin-angiotensin-aldosterone system (RAAS)	6/592	31/5488	0.109952288097863	0.401453703054988	0.328376478529725	1636/183/1215/84699/9586/3283	6
WP98	Prostaglandin synthesis and regulation	7/592	39/5488	0.120545367329147	0.432227689296369	0.353548629528374	301/1909/3290/5730/9536/5737/5743	7
WP3893	Development and heterogeneity of the ILC family	4/592	18/5488	0.121133874707263	0.432227689296369	0.353548629528374	3553/3569/30009/7124	4
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	4/592	18/5488	0.121133874707263	0.432227689296369	0.353548629528374	3569/3791/4318/6696	4
WP2873	Aryl hydrocarbon receptor pathway	6/592	32/5488	0.123698601040315	0.43806045932322	0.358319651608668	1545/2939/3553/3726/8140/7124	6
WP247	Small ligand GPCRs	3/592	12/5488	0.131562231501761	0.461835314082372	0.377766733610791	5724/5737/8698	3
WP3941	Oxidative damage response	7/592	40/5488	0.1333537212637	0.461835314082372	0.377766733610791	715/717/721/728/7124/7133/7185	7
WP4917	Proximal tubule transport	7/592	40/5488	0.1333537212637	0.461835314082372	0.377766733610791	5243/1244/6514/142680/6519/340024/11136	7
WP3645	NAD+ biosynthetic pathways	4/592	19/5488	0.141065562823705	0.4829153211238	0.395009515099589	952/3620/10135/6999	4
WP3869	Cannabinoid receptor signaling	5/592	26/5488	0.141491113195508	0.4829153211238	0.395009515099589	1557/1559/1576/5600/6300	5
WP4655	Cytosolic DNA-sensing pathway	9/592	56/5488	0.143894951153759	0.487586489161298	0.398830383356878	834/843/6351/3627/3553/3569/3665/9636/81030	9
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	7/592	41/5488	0.146804318392432	0.493529165824311	0.403691305602186	330/6347/3569/4318/7124/51330/7185	7
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	15/592	104/5488	0.147744399960144	0.493529165824311	0.403691305602186	8553/720/721/1051/3091/3552/3553/3557/3569/3764/6507/6532/6752/7124/11076	15
WP236	Adipogenesis	15/592	105/5488	0.156300218181881	0.513285756873468	0.419851574512659	183/1051/1271/1959/4616/3091/3569/10135/5008/6319/5054/8651/9021/6772/7124	15
WP1434	Osteopontin signaling	3/592	13/5488	0.158017908166991	0.513285756873468	0.419851574512659	4318/5328/6696	3
WP3591	Sleep regulation	3/592	13/5488	0.158017908166991	0.513285756873468	0.419851574512659	100/3569/5730	3
WP5178	Disorders of fructose metabolism	3/592	13/5488	0.158017908166991	0.513285756873468	0.419851574512659	229/3795/6514	3
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	8/592	50/5488	0.165283137802085	0.53320793085467	0.436147285043713	1003/1277/1278/3082/3791/4313/4318/7043	8
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	5/592	28/5488	0.177782078120705	0.564957316448906	0.46211728197631	9509/1277/1278/60681/4982	5
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	8/592	51/5488	0.17881571141786	0.564957316448906	0.46211728197631	348/602/8870/3575/8767/9021/7124/7185	8
WP262	Ebstein-Barr virus LMP1 signaling	4/592	21/5488	0.184369141243773	0.564957316448906	0.46211728197631	6364/9260/7124/7185	4
WP272	Blood clotting cascade	3/592	14/5488	0.18592013598637	0.564957316448906	0.46211728197631	5328/5054/7450	3
WP3935	Leptin-insulin signaling overlap	3/592	14/5488	0.18592013598637	0.564957316448906	0.46211728197631	8503/8651/9021	3
WP4225	Pyrimidine metabolism and related diseases	3/592	14/5488	0.18592013598637	0.564957316448906	0.46211728197631	1373/5009/1890	3
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	3/592	14/5488	0.18592013598637	0.564957316448906	0.46211728197631	3589/3569/3718	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/592	14/5488	0.18592013598637	0.564957316448906	0.46211728197631	941/1493/8503	3
WP5061	Fatty acid transporters	3/592	14/5488	0.18592013598637	0.564957316448906	0.46211728197631	2180/2182/2172	3
WP69	T-cell receptor signaling pathway	12/592	85/5488	0.201291730664117	0.607746186812815	0.49711722957535	1234/9308/29851/3601/3552/3553/3569/3937/1326/8767/3604/7535	12
WP4585	Cancer immunotherapy by PD-1 blockade	4/592	22/5488	0.207462096266326	0.622386288798978	0.50909237166259	10538/29126/80380/7535	4
WP3	Transcriptional activation by NRF2 in response to phytochemicals	3/592	15/5488	0.214970089715626	0.635213077265063	0.519584280431363	1051/2939/23657	3
WP4963	p53 transcriptional gene network	11/592	78/5488	0.215667381013694	0.635213077265063	0.519584280431363	6347/55332/3383/10379/9636/4688/5371/5268/5054/23657/7124	11
WP2371	Parkinson's disease pathway	5/592	30/5488	0.217132283311412	0.635213077265063	0.519584280431363	120892/5600/6300/9627/9246	5
WP3298	Melatonin metabolism and effects	5/592	30/5488	0.217132283311412	0.635213077265063	0.519584280431363	348/1545/1557/1565/406938	5
WP534	Glycolysis and gluconeogenesis	6/592	38/5488	0.221322464530928	0.643474572802884	0.526341923445873	229/3099/3101/5313/6514/6515	6
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	4/592	23/5488	0.231324860928259	0.665172237220955	0.544089929205207	2254/5600/6300/6772	4
WP5087	Malignant pleural mesothelioma	43/592	356/5488	0.231609866038719	0.665172237220955	0.544089929205207	72/285/467/834/6347/6351/29126/960/1001/1003/1282/1284/1440/115908/2919/3627/6374/2252/2254/1839/3082/3091/3620/3553/3569/3689/3791/3918/10319/4313/4314/4318/114548/5159/5228/5328/6401/6423/6425/8140/6678/6772/7474	43
WP306	Focal adhesion	22/592	173/5488	0.235083151521269	0.671055541615259	0.548902286805643	330/1277/1278/1282/1284/1290/50509/2268/2318/3055/3082/3678/3791/3918/10319/5159/5228/8503/6696/7058/3371/7450	22
WP254	Apoptosis	11/592	80/5488	0.240670547287786	0.682866432364741	0.558563223255102	330/834/843/837/3002/3659/3665/5551/7124/7133/7185	11
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	3/592	16/5488	0.244881959316116	0.690655106813717	0.564934113518428	3569/64386/7535	3
WP2324	AGE/RAGE pathway	9/592	64/5488	0.249103899700592	0.698380575946303	0.571253303824666	249/3091/4322/4313/4316/4318/653361/4843/6772	9
WP4666	Hepatitis B infection	17/592	132/5488	0.253693026237018	0.707037960696067	0.578334771739324	843/84699/9586/1959/1960/3569/3665/3718/5600/6300/4318/8503/6772/6775/7043/7097/7124	17
WP4950	16p11.2 distal deletion syndrome	4/592	24/5488	0.255814432519234	0.708756457156231	0.579740447690649	8519/3791/5350/7185	4
WP3877	MYD88 distinct input-output pathway	3/592	17/5488	0.275387318392806	0.754112947459371	0.616840627489395	3552/7097/51311	3
WP4912	SARS coronavirus and innate immunity	3/592	17/5488	0.275387318392806	0.754112947459371	0.616840627489395	59272/10379/6772	3
WP5083	Neuroinflammation and glutamatergic signaling	13/592	100/5488	0.279155651272329	0.760013362712527	0.621666981233177	2893/116443/3552/3553/3569/29968/6507/6515/9021/6772/7043/7124/7133	13
WP205	IL-7 signaling pathway	4/592	25/5488	0.280790619734795	0.760071160316601	0.621714257851997	3559/3575/3718/6772	4
WP2881	Estrogen receptor pathway	2/592	10/5488	0.29448742326449	0.774880314846785	0.63382767959308	1545/8431	2
WP3630	NAD metabolism, sirtuins and aging	2/592	10/5488	0.29448742326449	0.774880314846785	0.63382767959308	3091/10135	2
WP4846	SARS-CoV-2 and COVID-19 pathway	2/592	10/5488	0.29448742326449	0.774880314846785	0.63382767959308	59272/340024	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/592	10/5488	0.29448742326449	0.774880314846785	0.63382767959308	1244/9420	2
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	2/592	10/5488	0.29448742326449	0.774880314846785	0.63382767959308	3665/51311	2
WP5098	T-cell activation SARS-CoV-2	10/592	76/5488	0.301295144880129	0.779665412746974	0.637741738887904	941/1493/29851/3594/3595/8809/3937/6775/7124/7535	10
WP3851	TLR4 signaling and tolerance	4/592	26/5488	0.306117802741939	0.779665412746974	0.637741738887904	3569/11213/3665/7124	4
WP4545	Oxysterols derived from cholesterol	4/592	26/5488	0.306117802741939	0.779665412746974	0.637741738887904	9023/1576/9420/3638	4
WP3599	Transcription factor regulation in adipogenesis	3/592	18/5488	0.306238007129915	0.779665412746974	0.637741738887904	1051/3569/7124	3
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/592	18/5488	0.306238007129915	0.779665412746974	0.637741738887904	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/592	18/5488	0.306238007129915	0.779665412746974	0.637741738887904	2180/7124/7185	3
WP4816	TGF-beta receptor signaling in skeletal dysplasias	7/592	51/5488	0.308938188792578	0.782311220007013	0.6399059258522	2022/2200/3624/5054/6696/6772/7124	7
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	7/592	52/5488	0.327001580865637	0.814486629979395	0.666224397301282	843/3627/3665/9636/5600/6300/7124	7
WP395	IL-4 signaling pathway	7/592	52/5488	0.327001580865637	0.814486629979395	0.666224397301282	1051/9046/3718/5600/8651/9021/6772	7
WP4008	NO/cGMP/PKG mediated neuroprotection	4/592	27/5488	0.331666351126804	0.814486629979395	0.666224397301282	3553/4843/5593/7124	4
WP408	Oxidative stress response	4/592	27/5488	0.331666351126804	0.814486629979395	0.666224397301282	1536/3726/6648/7498	4
WP229	Irinotecan pathway	2/592	11/5488	0.336182691132838	0.814486629979395	0.666224397301282	1244/1576	2
WP3871	Valproic acid pathway	2/592	11/5488	0.336182691132838	0.814486629979395	0.666224397301282	1555/1559	2
WP4271	Vitamin B12 disorders	2/592	11/5488	0.336182691132838	0.814486629979395	0.666224397301282	8029/6947	2
WP692	Sulfation biotransformation reaction	2/592	11/5488	0.336182691132838	0.814486629979395	0.666224397301282	6783/6822	2
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	3/592	19/5488	0.337207840437329	0.814486629979395	0.666224397301282	941/3101/6515	3
WP4630	Measles virus infection	14/592	114/5488	0.344665867437325	0.828253181443775	0.677485002588941	3310/3552/3553/3559/3569/3665/10379/3718/4939/8503/6504/6772/7097/7128	14
WP4241	Type 2 papillary renal cell carcinoma	4/592	28/5488	0.357313729961154	0.849973569756078	0.695251595777684	1513/112399/3091/7043	4
WP4823	Genes controlling nephrogenesis	4/592	28/5488	0.357313729961154	0.849973569756078	0.695251595777684	7852/3791/5159/6469	4
WP2018	RANKL/RANK signaling pathway	7/592	54/5488	0.363560123388087	0.860486523194921	0.703850860407511	1513/3383/4067/6688/6772/4982/7185	7
WP3640	Imatinib and chronic myeloid leukemia	3/592	20/5488	0.36809339801064	0.860528649878233	0.703885318706969	5243/5159/11040	3
WP4224	Purine metabolism and related disorders	3/592	20/5488	0.36809339801064	0.860528649878233	0.703885318706969	100/316/7498	3
WP2828	Bladder cancer	5/592	37/5488	0.369058996338435	0.860528649878233	0.703885318706969	1839/4312/4313/4318/1890	5
WP4018	Clear cell renal cell carcinoma pathways	10/592	81/5488	0.375510221833518	0.862219877770943	0.7052686898294	229/3091/3099/3101/3791/4199/5159/5313/29968/7043	10
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	2/592	12/5488	0.377106783059053	0.862219877770943	0.7052686898294	249/7124	2
WP4792	Purine metabolism	2/592	12/5488	0.377106783059053	0.862219877770943	0.7052686898294	100/7498	2
WP5171	Leukotriene metabolic pathway	2/592	12/5488	0.377106783059053	0.862219877770943	0.7052686898294	240/1800	2
WP4658	Small cell lung cancer	11/592	91/5488	0.392182500139297	0.889944734430402	0.727946748913906	330/1282/1284/4616/3918/10319/4843/8503/5743/5915/7185	11
WP289	Myometrial relaxation and contraction pathways	14/592	118/5488	0.394824063234671	0.889944734430402	0.727946748913906	133/409/467/2786/3488/3553/3569/23764/5142/10268/6004/10287/5999/8490	14
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	6/592	47/5488	0.39681667324296	0.889944734430402	0.727946748913906	1051/1513/3726/4129/6696/4982	6
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	3/592	21/5488	0.398714107471785	0.889944734430402	0.727946748913906	5600/6300/7124	3
WP3925	Amino acid metabolism	9/592	74/5488	0.404587645041552	0.889944734430402	0.727946748913906	384/445/586/875/1373/3067/4942/5009/6999	9
WP560	TGF-beta receptor signaling	6/592	48/5488	0.416911984167213	0.889944734430402	0.727946748913906	2022/3624/5054/6696/6772/7124	6
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/592	13/5488	0.416941123948519	0.889944734430402	0.727946748913906	4312/5743	2
WP2855	Dopaminergic neurogenesis	2/592	13/5488	0.416941123948519	0.889944734430402	0.727946748913906	4929/6469	2
WP3644	NAD+ metabolism	2/592	13/5488	0.416941123948519	0.889944734430402	0.727946748913906	952/10135	2
WP4760	PKC-gamma calcium signaling pathway in ataxia	2/592	13/5488	0.416941123948519	0.889944734430402	0.727946748913906	2769/2893	2
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	2/592	13/5488	0.416941123948519	0.889944734430402	0.727946748913906	56624/3091	2
WP698	Glucuronidation	2/592	13/5488	0.416941123948519	0.889944734430402	0.727946748913906	79799/7364	2
WP4217	Ebola virus infection in host	14/592	120/5488	0.420173286930135	0.889944734430402	0.727946748913906	684/11314/2318/3106/3107/3108/3119/3133/3134/3665/3678/8503/9021/6772	14
WP536	Calcium regulation in cardiac cells	12/592	102/5488	0.420844196405091	0.889944734430402	0.727946748913906	409/775/2701/2702/10052/2786/3760/5350/6004/10287/5999/8490	12
WP382	MAPK signaling pathway	22/592	193/5488	0.425143866461237	0.889944734430402	0.727946748913906	409/775/994/1843/11221/1844/1846/2252/2254/2318/3310/3552/3553/120892/1326/5600/6300/22808/5159/115727/7043/7124	22
WP357	Fatty acid biosynthesis	3/592	22/5488	0.428911793451595	0.889944734430402	0.727946748913906	2180/2182/6319	3
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	3/592	22/5488	0.428911793451595	0.889944734430402	0.727946748913906	1244/5600/6300	3
WP3845	Canonical and non-canonical Notch signaling	3/592	22/5488	0.428911793451595	0.889944734430402	0.727946748913906	4237/4854/4855	3
WP4482	Vitamin D in inflammatory diseases	3/592	22/5488	0.428911793451595	0.889944734430402	0.727946748913906	1843/3569/7124	3
WP4483	Relationship between inflammation, COX-2 and EGFR	3/592	22/5488	0.428911793451595	0.889944734430402	0.727946748913906	4312/51365/5743	3
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3/592	22/5488	0.428911793451595	0.889944734430402	0.727946748913906	3553/3569/10135	3
WP5220	Metabolic reprogramming in pancreatic cancer	5/592	40/5488	0.435961311396989	0.898658895943796	0.735074658432069	3099/3949/4199/9122/8140	5
WP2637	Interleukin-1 (IL-1) structural pathway	6/592	49/5488	0.436927573611739	0.898658895943796	0.735074658432069	3552/3556/3656/3665/1326/5600	6
WP2895	Differentiation of white and brown adipocyte	2/592	14/5488	0.45544462194221	0.927301473474844	0.758503384270406	1051/51316	2
WP4357	NRF2-ARE regulation	3/592	23/5488	0.458549833330095	0.927301473474844	0.758503384270406	1051/2939/23657	3
WP4900	Purinergic signaling	3/592	23/5488	0.458549833330095	0.927301473474844	0.758503384270406	5027/53829/5031	3
WP4564	Neural crest cell migration during development	4/592	32/5488	0.458728754394137	0.927301473474844	0.758503384270406	2151/4313/4318/8503	4
WP3594	Circadian rhythm genes	16/592	142/5488	0.466518007088818	0.939017014268518	0.768086327460672	100/56938/8553/1960/50865/3569/4547/10135/4843/5371/5551/5593/60675/5730/5054/6532	16
WP4313	Ferroptosis	7/592	60/5488	0.473657015495193	0.949329592758451	0.776521691696487	2180/2182/246/875/1536/1803/23657	7
WP4787	Osteoblast differentiation and related diseases	10/592	88/5488	0.481279892304117	0.958427981408009	0.783963886904305	2252/2254/5600/6300/4854/4855/5288/8503/6772/7474	10
WP1539	Angiogenesis	3/592	24/5488	0.487512033445932	0.958427981408009	0.783963886904305	3091/3791/4318	3
WP197	Cholesterol biosynthesis pathway	2/592	15/5488	0.492440703823223	0.958427981408009	0.783963886904305	4597/6713	2
WP22	IL-9 signaling pathway	2/592	15/5488	0.492440703823223	0.958427981408009	0.783963886904305	3718/6772	2
WP4558	Overview of interferons-mediated signaling pathway	2/592	15/5488	0.492440703823223	0.958427981408009	0.783963886904305	10379/6772	2
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/592	15/5488	0.492440703823223	0.958427981408009	0.783963886904305	2254/5600	2
WP5182	Pro-survival signaling of neuroprotectin D1	2/592	15/5488	0.492440703823223	0.958427981408009	0.783963886904305	330/7124	2
WP585	Interferon type I signaling pathways	6/592	52/5488	0.496037297485805	0.961455008707055	0.786439899847541	10379/8651/9021/6772/6775/7535	6
WP2267	Synaptic vesicle pathway	4/592	34/5488	0.507465287433446	0.979574386808005	0.801260980158073	246213/6507/6581/6532	4
WP195	IL-1 signaling pathway	6/592	53/5488	0.515290109134103	0.990618944498623	0.810295080313993	6347/3552/3553/3556/3656/11213	6
WP4673	Male infertility	10/592	91/5488	0.525646820110605	0.998380475713147	0.816643768266872	5243/338/94240/2346/4313/4318/4843/29968/6648/7124	10
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	2/592	16/5488	0.52780623875281	0.998380475713147	0.816643768266872	3949/6319	2
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	2/592	16/5488	0.52780623875281	0.998380475713147	0.816643768266872	7852/3371	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/592	16/5488	0.52780623875281	0.998380475713147	0.816643768266872	2180/2182	2
WP4565	Neural crest cell migration in cancer	4/592	35/5488	0.531086891958851	0.999999573275476	0.817968139052016	2151/4313/4318/8503	4
WP5038	Mitochondrial immune response to SARS-CoV-2	3/592	26/5488	0.543038297271885	0.999999573275476	0.817968139052016	1636/59272/3665	3
WP3303	RAC1/PAK1/p38/MMP2 pathway	7/592	64/5488	0.54443930624426	0.999999573275476	0.817968139052016	285/9046/5600/6300/4313/4843/79931	7
WP100	Glutathione metabolism	2/592	17/5488	0.561462094800811	0.999999573275476	0.817968139052016	290/2938	2
WP1584	Type II diabetes mellitus	2/592	17/5488	0.561462094800811	0.999999573275476	0.817968139052016	6514/7124	2
WP325	Triacylglyceride synthesis	2/592	17/5488	0.561462094800811	0.999999573275476	0.817968139052016	56895/2819	2
WP3874	Canonical and non-canonical TGF-B signaling	2/592	17/5488	0.561462094800811	0.999999573275476	0.817968139052016	26585/4017	2
WP4784	Proteoglycan biosynthesis	2/592	17/5488	0.561462094800811	0.999999573275476	0.817968139052016	9469/55790	2
WP4541	Hippo-Merlin signaling dysregulation	10/592	94/5488	0.568710236868896	0.999999573275476	0.817968139052016	960/1001/1003/3627/3678/3684/3687/3689/3791/5159	10
WP2643	Nanoparticle-mediated activation of receptor signaling	3/592	27/5488	0.569459790540021	0.999999573275476	0.817968139052016	1277/5600/6300	3
WP2839	Hair follicle development: organogenesis - part 2 of 3	3/592	27/5488	0.569459790540021	0.999999573275476	0.817968139052016	3624/6469/7474	3
WP2870	Extracellular vesicle-mediated signaling in recipient cells	3/592	27/5488	0.569459790540021	0.999999573275476	0.817968139052016	3082/7043/7474	3
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	6/592	56/5488	0.571203793979752	0.999999573275476	0.817968139052016	1493/29851/3937/1326/7124/7535	6
WP34	Ovarian infertility	2/592	18/5488	0.593365105759672	0.999999573275476	0.817968139052016	1051/2701	2
WP5193	Cholesterol synthesis disorders	2/592	18/5488	0.593365105759672	0.999999573275476	0.817968139052016	4597/6713	2
WP5194	Synthesis of ceramides and 1-deoxyceramides	2/592	18/5488	0.593365105759672	0.999999573275476	0.817968139052016	53947/8877	2
WP4149	White fat cell differentiation	3/592	28/5488	0.594917317809485	0.999999573275476	0.817968139052016	1051/1959/10365	3
WP2359	Parkin-ubiquitin proteasomal system pathway	6/592	58/5488	0.606659773589636	0.999999573275476	0.817968139052016	834/3310/9627/10381/84617/9246	6
WP5072	Modulators of TCR signaling and T cell activation	6/592	59/5488	0.62377298461245	0.999999573275476	0.817968139052016	3937/1326/399/8651/7128/7535	6
WP49	IL-2 signaling pathway	4/592	40/5488	0.639832993250964	0.999999573275476	0.817968139052016	3559/3718/9021/6772	4
WP3858	Toll-like receptor signaling related to MyD88	3/592	30/5488	0.642811246796613	0.999999573275476	0.817968139052016	3665/7097/51311	3
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	3/592	30/5488	0.642811246796613	0.999999573275476	0.817968139052016	409/3283/4318	3
WP2878	PPAR-alpha pathway	2/592	20/5488	0.651879905355622	0.999999573275476	0.817968139052016	335/345	2
WP3580	Methionine de novo and salvage pathway	2/592	20/5488	0.651879905355622	0.999999573275476	0.817968139052016	51074/259307	2
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	5/592	51/5488	0.657187191131687	0.999999573275476	0.817968139052016	1959/2619/3488/22822/7474	5
WP1772	Apoptosis modulation and signaling	8/592	81/5488	0.65843987979335	0.999999573275476	0.817968139052016	597/330/664/834/843/837/8794/7133	8
WP2332	Interleukin-11 signaling pathway	4/592	41/5488	0.659494388929225	0.999999573275476	0.817968139052016	3383/3589/9021/6772	4
WP2586	Aryl hydrocarbon receptor pathway	4/592	41/5488	0.659494388929225	0.999999573275476	0.817968139052016	1545/135112/5743/7124	4
WP314	Fas ligand pathway and stress induction of heat shock proteins	4/592	41/5488	0.659494388929225	0.999999573275476	0.817968139052016	843/3552/8767/7124	4
WP4290	Metabolic reprogramming in colon cancer	4/592	41/5488	0.659494388929225	0.999999573275476	0.817968139052016	229/3101/29968/9123	4
WP231	TNF-alpha signaling pathway	9/592	92/5488	0.67307312626988	0.999999573275476	0.817968139052016	330/6347/3569/1326/6401/7124/7128/7133/7185	9
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	2/592	21/5488	0.678528936711816	0.999999573275476	0.817968139052016	409/2769	2
WP2333	Trans-sulfuration pathway	1/592	10/5488	0.680962342693954	0.999999573275476	0.817968139052016	875	1
WP2436	Dopamine metabolism	1/592	10/5488	0.680962342693954	0.999999573275476	0.817968139052016	4129	1
WP3930	EDA signaling in hair follicle development	1/592	10/5488	0.680962342693954	0.999999573275476	0.817968139052016	6469	1
WP4589	Major receptors targeted by epinephrine and norepinephrine	1/592	10/5488	0.680962342693954	0.999999573275476	0.817968139052016	150	1
WP5050	TCA cycle in senescence	1/592	10/5488	0.680962342693954	0.999999573275476	0.817968139052016	4199	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/592	10/5488	0.680962342693954	0.999999573275476	0.817968139052016	629	1
WP410	Exercise-induced circadian regulation	4/592	43/5488	0.696596950298349	0.999999573275476	0.817968139052016	1051/50486/3108/10381	4
WP26	S1P receptor signal transduction	2/592	22/5488	0.703490651037838	0.999999573275476	0.817968139052016	6300/8877	2
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	3/592	33/5488	0.706895985702114	0.999999573275476	0.817968139052016	10379/4939/6772	3
WP4504	Cysteine and methionine catabolism	1/592	11/5488	0.715440307850066	0.999999573275476	0.817968139052016	875	1
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	1/592	11/5488	0.715440307850066	0.999999573275476	0.817968139052016	604	1
WP4788	Autosomal recessive osteopetrosis pathways	1/592	11/5488	0.715440307850066	0.999999573275476	0.817968139052016	29887	1
WP4919	Neuroinflammation	1/592	11/5488	0.715440307850066	0.999999573275476	0.817968139052016	4843	1
WP4947	Nitric oxide metabolism in cystic fibrosis	1/592	11/5488	0.715440307850066	0.999999573275476	0.817968139052016	4843	1
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	1/592	11/5488	0.715440307850066	0.999999573275476	0.817968139052016	2358	1
WP183	Proteasome degradation	5/592	55/5488	0.722279069620821	0.999999573275476	0.817968139052016	3106/3107/3133/3134/5698	5
WP4249	Hedgehog signaling pathway	3/592	34/5488	0.726195730695855	0.999999573275476	0.817968139052016	409/2619/6469	3
WP1528	Physiological and pathological hypertrophy of the heart	2/592	23/5488	0.726818347962385	0.999999573275476	0.817968139052016	183/5600	2
WP286	IL-3 signaling pathway	4/592	45/5488	0.730715898048612	0.999999573275476	0.817968139052016	1439/3055/3563/4067	4
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	6/592	66/5488	0.73079007098594	0.999999573275476	0.817968139052016	467/283120/5328/6423/6425/7474	6
WP4659	Gastrin signaling pathway	10/592	107/5488	0.731937004275285	0.999999573275476	0.817968139052016	409/330/960/9076/3067/4316/8503/5743/5054/7032	10
WP5205	Clock-controlled autophagy in bone metabolism	6/592	67/5488	0.744166476206291	0.999999573275476	0.817968139052016	8553/115908/1513/3569/4982/7474	6
WP3940	One-carbon metabolism and related pathways	3/592	35/5488	0.74448718432745	0.999999573275476	0.817968139052016	64902/586/6648	3
WP2513	Nanoparticle triggered regulated necrosis	1/592	12/5488	0.746197901012885	0.999999573275476	0.817968139052016	7124	1
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	1/592	12/5488	0.746197901012885	0.999999573275476	0.817968139052016	4597	1
WP47	Hedgehog signaling pathway	1/592	12/5488	0.746197901012885	0.999999573275476	0.817968139052016	6469	1
WP5173	Disorders of galactose metabolism 	1/592	12/5488	0.746197901012885	0.999999573275476	0.817968139052016	6514	1
WP2197	Endothelin pathways	2/592	24/5488	0.748573467463881	0.999999573275476	0.817968139052016	1909/2769	2
WP241	One-carbon metabolism	2/592	24/5488	0.748573467463881	0.999999573275476	0.817968139052016	2346/2745	2
WP3613	Photodynamic therapy-induced unfolded protein response	2/592	24/5488	0.748573467463881	0.999999573275476	0.817968139052016	467/6783	2
WP4698	Vitamin D-sensitive calcium signaling in depression	2/592	24/5488	0.748573467463881	0.999999573275476	0.817968139052016	775/1594	2
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	2/592	24/5488	0.748573467463881	0.999999573275476	0.817968139052016	1959/26353	2
WP581	EPO receptor signaling	2/592	24/5488	0.748573467463881	0.999999573275476	0.817968139052016	8651/6772	2
WP4758	Nephrotic syndrome	3/592	36/5488	0.761791737652239	0.999999573275476	0.817968139052016	8542/1493/8029	3
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2/592	25/5488	0.768823219666495	0.999999573275476	0.817968139052016	2562/8503	2
WP4584	Biomarkers for pyrimidine metabolism disorders	1/592	13/5488	0.773635965768248	0.999999573275476	0.817968139052016	1890	1
WP4962	Airway smooth muscle cell contraction	1/592	13/5488	0.773635965768248	0.999999573275476	0.817968139052016	952	1
WP5037	Riboflavin and CoQ disorders	1/592	13/5488	0.773635965768248	0.999999573275476	0.817968139052016	55065	1
WP2272	Pathogenic Escherichia coli infection	4/592	48/5488	0.776377740060747	0.999999573275476	0.817968139052016	9076/23643/10381/84617	4
WP127	IL-5 signaling pathway	3/592	37/5488	0.778134760943553	0.999999573275476	0.817968139052016	1439/4067/6772	3
WP1422	Sphingolipid pathway	2/592	26/5488	0.787638629866045	0.999999573275476	0.817968139052016	56624/8877	2
WP2525	Trans-sulfuration and one-carbon metabolism	2/592	26/5488	0.787638629866045	0.999999573275476	0.817968139052016	875/29968	2
WP5102	Familial partial lipodystrophy (FPLD)	2/592	26/5488	0.787638629866045	0.999999573275476	0.817968139052016	10365/5396	2
WP3915	Angiopoietin-like protein 8 regulatory pathway	11/592	123/5488	0.788586294182611	0.999999573275476	0.817968139052016	64240/64241/1555/1576/1734/1326/5600/6300/5288/8503/6319	11
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	3/592	38/5488	0.79354483947157	0.999999573275476	0.817968139052016	775/116443/8503	3
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/592	14/5488	0.798112222985636	0.999999573275476	0.817968139052016	283120	1
WP4159	GABA receptor signaling	1/592	14/5488	0.798112222985636	0.999999573275476	0.817968139052016	2562	1
WP4830	GDNF/RET signaling axis	1/592	14/5488	0.798112222985636	0.999999573275476	0.817968139052016	26585	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/592	14/5488	0.798112222985636	0.999999573275476	0.817968139052016	3091	1
WP5200	Dravet syndrome	1/592	14/5488	0.798112222985636	0.999999573275476	0.817968139052016	5600	1
WP4906	3q29 copy number variation syndrome	4/592	50/5488	0.803274287929181	0.999999573275476	0.817968139052016	3091/375387/8503/200931	4
WP4746	Thyroid hormones production and peripheral downstream signaling effects	6/592	72/5488	0.80386235275083	0.999999573275476	0.817968139052016	1734/50506/405753/5593/6469/5172	6
WP2533	Glycerophospholipid biosynthetic pathway	2/592	27/5488	0.805092937012127	0.999999573275476	0.817968139052016	2819/5320	2
WP2636	Common pathways underlying drug addiction	2/592	27/5488	0.805092937012127	0.999999573275476	0.817968139052016	72/2893	2
WP3998	Prader-Willi and Angelman syndrome	2/592	27/5488	0.805092937012127	0.999999573275476	0.817968139052016	9638/2562	2
WP4561	Cell migration and invasion through p75NTR	2/592	27/5488	0.805092937012127	0.999999573275476	0.817968139052016	4313/4318	2
WP1946	Cori cycle	1/592	15/5488	0.819945902925808	0.999999573275476	0.817968139052016	6514	1
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	1/592	15/5488	0.819945902925808	0.999999573275476	0.817968139052016	201294	1
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	1/592	15/5488	0.819945902925808	0.999999573275476	0.817968139052016	3371	1
WP3927	BMP signaling in eyelid development	1/592	15/5488	0.819945902925808	0.999999573275476	0.817968139052016	6469	1
WP4970	Galanin receptor pathway	1/592	15/5488	0.819945902925808	0.999999573275476	0.817968139052016	3569	1
WP5074	Kallmann syndrome	1/592	15/5488	0.819945902925808	0.999999573275476	0.817968139052016	60675	1
WP143	Fatty acid beta-oxidation	2/592	28/5488	0.821260292335408	0.999999573275476	0.817968139052016	2180/2182	2
WP170	Nuclear receptors	2/592	28/5488	0.821260292335408	0.999999573275476	0.817968139052016	4929/5915	2
WP2363	Gastric cancer network 2	2/592	28/5488	0.821260292335408	0.999999573275476	0.817968139052016	962/51316	2
WP2583	T cell receptor and co-stimulatory signaling	2/592	28/5488	0.821260292335408	0.999999573275476	0.817968139052016	1493/7535	2
WP4481	Resistin as a regulator of inflammation	2/592	28/5488	0.821260292335408	0.999999573275476	0.817968139052016	3569/7124	2
WP2037	Prolactin signaling pathway	6/592	75/5488	0.834138578256285	0.999999573275476	0.817968139052016	3659/4843/8651/9021/6772/7535	6
WP1591	Heart development	2/592	29/5488	0.836214712169097	0.999999573275476	0.817968139052016	8553/6469	2
WP3972	PDGFR-beta pathway	2/592	29/5488	0.836214712169097	0.999999573275476	0.817968139052016	5159/6772	2
WP4815	Glycosaminoglycan degradation	1/592	16/5488	0.839421880537342	0.999999573275476	0.817968139052016	3373	1
WP4875	Disruption of postsynaptic signaling by CNV	1/592	16/5488	0.839421880537342	0.999999573275476	0.817968139052016	9378	1
WP399	Wnt signaling pathway and pluripotency	6/592	76/5488	0.843357503701427	0.999999573275476	0.817968139052016	960/3949/120892/4316/5328/7474	6
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	5/592	65/5488	0.844984976137694	0.999999573275476	0.817968139052016	3638/3949/4597/6319/6713	5
WP4844	Influence of laminopathies on Wnt signaling	2/592	30/5488	0.850029245409989	0.999999573275476	0.817968139052016	1051/6696	2
WP1971	Integrated cancer pathway	3/592	43/5488	0.857746819355946	0.999999573275476	0.817968139052016	994/4312/6772	3
WP2447	Amyotrophic lateral sclerosis (ALS)	2/592	31/5488	0.862775321618906	0.999999573275476	0.817968139052016	834/7124	2
WP304	Kit receptor signaling pathway	4/592	56/5488	0.868520327069109	0.999999573275476	0.817968139052016	3726/4067/8651/6772	4
WP3670	Interactions between LOXL4 and oxidative stress pathway	1/592	18/5488	0.872290206050946	0.999999573275476	0.817968139052016	2252	1
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1/592	18/5488	0.872290206050946	0.999999573275476	0.817968139052016	8877	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/592	18/5488	0.872290206050946	0.999999573275476	0.817968139052016	22808	1
WP4722	Glycerolipids and glycerophospholipids	1/592	18/5488	0.872290206050946	0.999999573275476	0.817968139052016	56895	1
WP5103	Progeria-associated lipodystrophy	1/592	18/5488	0.872290206050946	0.999999573275476	0.817968139052016	2200	1
WP3527	Pre-implantation embryo	2/592	32/5488	0.874522250579707	0.999999573275476	0.817968139052016	366/7538	2
WP3995	Prion disease pathway	2/592	32/5488	0.874522250579707	0.999999573275476	0.817968139052016	10538/6688	2
WP4222	Phosphodiesterases in neuronal function	2/592	32/5488	0.874522250579707	0.999999573275476	0.817968139052016	10846/5142	2
WP4542	Leukocyte-intrinsic Hippo pathway functions	2/592	32/5488	0.874522250579707	0.999999573275476	0.817968139052016	50943/639	2
WP4806	EGFR tyrosine kinase inhibitor resistance	6/592	80/5488	0.876154460747705	0.999999573275476	0.817968139052016	3082/3569/3791/22808/5159/8503	6
WP5053	Development of ureteric collection system	3/592	45/5488	0.878087536445666	0.999999573275476	0.817968139052016	158326/5915/6469	3
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/592	19/5488	0.886111814463713	0.999999573275476	0.817968139052016	3002	1
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	1/592	19/5488	0.886111814463713	0.999999573275476	0.817968139052016	3091	1
WP2355	Corticotropin-releasing hormone signaling pathway	5/592	70/5488	0.887196858546116	0.999999573275476	0.817968139052016	409/3283/3726/4929/6822	5
WP4321	Thermogenesis	7/592	93/5488	0.887878636452985	0.999999573275476	0.817968139052016	2180/2182/84699/9586/5600/6300/5593	7
WP4657	22q11.2 copy number variation syndrome	6/592	82/5488	0.890271285489519	0.999999573275476	0.817968139052016	8854/9076/4942/5625/6469/7450	6
WP4312	Rett syndrome causing genes	2/592	34/5488	0.895283168164863	0.999999573275476	0.817968139052016	3766/23221	2
WP500	Glycogen synthesis and degradation	2/592	34/5488	0.895283168164863	0.999999573275476	0.817968139052016	3099/3101	2
WP2507	Nanomaterial induced apoptosis	1/592	20/5488	0.898439809679929	0.999999573275476	0.817968139052016	5551	1
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	1/592	20/5488	0.898439809679929	0.999999573275476	0.817968139052016	597	1
WP4725	Sphingolipid metabolism overview	1/592	20/5488	0.898439809679929	0.999999573275476	0.817968139052016	8877	1
WP5064	7-oxo-C and 7-beta-HC pathways	1/592	20/5488	0.898439809679929	0.999999573275476	0.817968139052016	3290	1
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	4/592	60/5488	0.900876716870382	0.999999573275476	0.817968139052016	941/9076/4311/5329	4
WP710	DNA damage response (only ATM dependent)	7/592	96/5488	0.905841825881614	0.999999573275476	0.817968139052016	604/3949/5288/8503/5328/6648/7474	7
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	4/592	61/5488	0.907780545806288	0.999999573275476	0.817968139052016	5328/6423/6425/7474	4
WP3658	Wnt/beta-catenin signaling pathway in leukemia	1/592	21/5488	0.909435353328334	0.999999573275476	0.817968139052016	5371	1
WP4686	Leucine, isoleucine and valine metabolism	1/592	21/5488	0.909435353328334	0.999999573275476	0.817968139052016	586	1
WP4726	Sphingolipid metabolism: integrated pathway	1/592	21/5488	0.909435353328334	0.999999573275476	0.817968139052016	8877	1
WP4905	1q21.1 copy number variation syndrome	1/592	21/5488	0.909435353328334	0.999999573275476	0.817968139052016	2702	1
WP3584	MECP2 and associated Rett syndrome	3/592	49/5488	0.911175358541715	0.999999573275476	0.817968139052016	604/2893/6890	3
WP623	Oxidative phosphorylation	2/592	36/5488	0.912812352879771	0.999999573275476	0.817968139052016	3002/56901	2
WP2361	Gastric cancer network 1	1/592	22/5488	0.919242243913596	0.999999573275476	0.817968139052016	6286	1
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/592	22/5488	0.919242243913596	0.999999573275476	0.817968139052016	1051	1
WP4537	Hippo-Yap signaling pathway	1/592	22/5488	0.919242243913596	0.999999573275476	0.817968139052016	3627	1
WP5085	Vasopressin-regulated water reabsorption	2/592	37/5488	0.920508215276127	0.999999573275476	0.817968139052016	84699/9586	2
WP4205	MET in type 1 papillary renal cell carcinoma	3/592	51/5488	0.924459875207723	0.999999573275476	0.817968139052016	3082/3718/8503	3
WP1544	MicroRNAs in cardiomyocyte hypertrophy	5/592	76/5488	0.924488117686784	0.999999573275476	0.817968139052016	183/8503/5320/7124/7474	5
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/592	23/5488	0.927988784638651	0.999999573275476	0.817968139052016	5054	1
WP4396	Nonalcoholic fatty liver disease	10/592	135/5488	0.928886072728265	0.999999573275476	0.817968139052016	6347/3552/3553/3569/56901/9971/8503/5313/9021/7124	10
WP3888	VEGFA-VEGFR2 signaling pathway	35/592	401/5488	0.931679819438019	0.999999573275476	0.817968139052016	56999/301/409/6347/1003/79094/1397/1536/1558/1847/1960/2022/6624/1839/3383/3791/6300/4319/4313/653361/4688/4855/4929/8013/8828/5228/5328/5329/5743/27289/6401/9047/6648/6772/8794	35
WP2526	PDGF pathway	2/592	39/5488	0.934021662936973	0.999999573275476	0.817968139052016	5159/6772	2
WP2858	Ectoderm differentiation	7/592	102/5488	0.934493265921149	0.999999573275476	0.817968139052016	6347/57476/3801/4061/6469/6781/4982	7
WP4150	Wnt signaling in kidney disease	1/592	24/5488	0.935789450602772	0.999999573275476	0.817968139052016	7474	1
WP4521	Glycosylation and related congenital defects	1/592	24/5488	0.935789450602772	0.999999573275476	0.817968139052016	79644	1
WP4925	Unfolded protein response	1/592	24/5488	0.935789450602772	0.999999573275476	0.817968139052016	3553	1
WP4255	Non-small cell lung cancer	4/592	66/5488	0.936278108404906	0.999999573275476	0.817968139052016	4616/3718/8503/5915	4
WP268	Notch signaling	2/592	40/5488	0.939933721089943	0.999999573275476	0.817968139052016	4854/4855	2
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	2/592	40/5488	0.939933721089943	0.999999573275476	0.817968139052016	72/3689	2
WP5121	Sphingolipid metabolism in senescence	1/592	25/5488	0.942746376891783	0.999999573275476	0.817968139052016	8877	1
WP61	Notch signaling pathway	3/592	55/5488	0.94572705838751	0.999999573275476	0.817968139052016	3091/4854/4855	3
WP3931	Embryonic stem cell pluripotency pathways	5/592	81/5488	0.94675209197145	0.999999573275476	0.817968139052016	2252/2254/6300/5159/7474	5
WP2112	IL-17 signaling pathway	1/592	26/5488	0.948950686772813	0.999999573275476	0.817968139052016	1051	1
WP2038	Microtubule cytoskeleton regulation	2/592	42/5488	0.950282542352835	0.999999573275476	0.817968139052016	2151/11076	2
WP5224	2q37 copy number variation syndrome	6/592	95/5488	0.95255754136759	0.999999573275476	0.817968139052016	1293/6373/7852/27128/3553/7124	6
WP3996	Ethanol effects on histone modifications	1/592	27/5488	0.954483677148224	0.999999573275476	0.817968139052016	8854	1
WP1601	Fluoropyrimidine activity	1/592	28/5488	0.959417876585736	0.999999573275476	0.817968139052016	1890	1
WP185	Integrin-mediated cell adhesion	5/592	85/5488	0.960088225248941	0.999999573275476	0.817968139052016	3678/3684/3687/3689/6300	5
WP4223	Ras signaling	10/592	146/5488	0.961576819028438	0.999999573275476	0.817968139052016	2786/3791/22808/5159/8503/51365/84647/5320/115727/7535	10
WP4566	Translation inhibitors in chronically activated PDGFRA cells	2/592	45/5488	0.96267664950589	0.999999573275476	0.817968139052016	8503/11040	2
WP722	Serotonin HTR1 group and FOS pathway	1/592	29/5488	0.963817989600615	0.999999573275476	0.817968139052016	3352	1
WP2034	Leptin signaling pathway	4/592	74/5488	0.965666213047119	0.999999573275476	0.817968139052016	3553/3557/9021/6772	4
WP4685	Melanoma	3/592	61/5488	0.967433532208476	0.999999573275476	0.817968139052016	4616/3791/8503	3
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	1/592	30/5488	0.967741739400292	0.999999573275476	0.817968139052016	8503	1
WP5124	Alzheimer's disease	15/592	208/5488	0.970342033502356	0.999999573275476	0.817968139052016	348/775/1536/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7474	15
WP3981	miRNA regulation of prostate cancer signaling pathways	1/592	31/5488	0.971240619993005	0.999999573275476	0.817968139052016	5159	1
WP4148	Splicing factor NOVA regulated synaptic proteins	1/592	31/5488	0.971240619993005	0.999999573275476	0.817968139052016	1600	1
WP366	TGF-beta signaling pathway	8/592	127/5488	0.971297302225669	0.999999573275476	0.817968139052016	467/1278/50943/3726/4312/4321/5371/3371	8
WP4262	Breast cancer pathway	7/592	115/5488	0.97177994900141	0.999999573275476	0.817968139052016	2252/2254/4616/4854/4855/8503/7474	7
WP3286	Copper homeostasis	2/592	48/5488	0.972075454328111	0.999999573275476	0.817968139052016	79689/54739	2
WP2059	Alzheimer's disease and miRNA effects	15/592	210/5488	0.973276199041348	0.999999573275476	0.817968139052016	348/775/1536/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7474	15
WP35	G protein signaling pathways	4/592	79/5488	0.977013636844006	0.999999573275476	0.817968139052016	2769/2786/3760/5142	4
WP244	Alpha 6 beta 4 signaling pathway	1/592	33/5488	0.977142558614674	0.999999573275476	0.817968139052016	3918	1
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1/592	33/5488	0.977142558614674	0.999999573275476	0.817968139052016	3488	1
WP400	p38 MAPK signaling pathway	1/592	33/5488	0.977142558614674	0.999999573275476	0.817968139052016	6772	1
WP422	MAPK cascade	1/592	33/5488	0.977142558614674	0.999999573275476	0.817968139052016	6300	1
WP4874	CAMKK2 pathway	1/592	33/5488	0.977142558614674	0.999999573275476	0.817968139052016	3383	1
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	7/592	119/5488	0.978520817135841	0.999999573275476	0.817968139052016	249/1959/2562/653361/4688/6696/6772	7
WP313	Hepatocyte growth factor receptor signaling	1/592	34/5488	0.979623146204063	0.999999573275476	0.817968139052016	3082	1
WP4540	Hippo signaling regulation pathways	4/592	81/5488	0.980477655255288	0.999999573275476	0.817968139052016	1001/1003/3791/5159	4
WP2118	Arrhythmogenic right ventricular cardiomyopathy	2/592	52/5488	0.981121957853011	0.999999573275476	0.817968139052016	775/3678	2
WP4263	Pancreatic adenocarcinoma pathway	4/592	82/5488	0.98201909004746	0.999999573275476	0.817968139052016	4616/8503/6772/7043	4
WP4932	7q11.23 copy number variation syndrome	4/592	82/5488	0.98201909004746	0.999999573275476	0.817968139052016	9076/2200/5313/9246	4
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	3/592	68/5488	0.982395208387626	0.999999573275476	0.817968139052016	4616/5743/7043	3
WP2795	Cardiac hypertrophic response	2/592	53/5488	0.982895274950566	0.999999573275476	0.817968139052016	5320/7124	2
WP1403	AMP-activated protein kinase (AMPK) signaling	2/592	55/5488	0.985969863432557	0.999999573275476	0.817968139052016	5209/8503	2
WP428	Wnt signaling	4/592	85/5488	0.985982041726777	0.999999573275476	0.817968139052016	5328/6423/6425/7474	4
WP2064	Neural crest differentiation	2/592	57/5488	0.988504318495292	0.999999573275476	0.817968139052016	4854/4855	2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	1/592	39/5488	0.988530639037709	0.999999573275476	0.817968139052016	7043	1
WP51	Regulation of actin cytoskeleton	6/592	115/5488	0.988708976756551	0.999999573275476	0.817968139052016	2252/2254/22808/5159/5288/8503	6
WP4155	Endometrial cancer	2/592	59/5488	0.990590625946243	0.999999573275476	0.817968139052016	4616/8503	2
WP4022	Pyrimidine metabolism	3/592	75/5488	0.990648850882631	0.999999573275476	0.817968139052016	953/956/1890	3
WP707	DNA damage response	2/592	62/5488	0.993044736242672	0.999999573275476	0.817968139052016	4616/5371	2
WP4971	Phosphoinositides metabolism	1/592	44/5488	0.993547938521214	0.999999573275476	0.817968139052016	5288	1
WP2853	Endoderm differentiation	5/592	110/5488	0.994307656974822	0.999999573275476	0.817968139052016	1844/1846/1847/6772/30009	5
WP1530	miRNA regulation of DNA damage response	2/592	65/5488	0.994869183154177	0.999999573275476	0.817968139052016	4616/5371	2
WP363	Wnt signaling pathway	1/592	48/5488	0.995929471758215	0.999999573275476	0.817968139052016	409	1
WP481	Insulin signaling	7/592	150/5488	0.997836328699343	0.999999573275476	0.817968139052016	1326/5600/6300/5288/8503/8651/9021	7
WP4016	DNA IR-damage and cellular response via ATR	2/592	75/5488	0.998162745082086	0.999999573275476	0.817968139052016	604/5371	2
WP673	ErbB signaling pathway	2/592	77/5488	0.99850705541512	0.999999573275476	0.817968139052016	1839/8503	2
WP23	B cell receptor signaling pathway	3/592	95/5488	0.998578205072154	0.999999573275476	0.817968139052016	604/27071/4067	3
WP2261	Glioblastoma signaling pathways	2/592	80/5488	0.998907712987766	0.999999573275476	0.817968139052016	5159/5288	2
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	1/592	61/5488	0.999091306569464	0.999999573275476	0.817968139052016	6772	1
WP45	G1 to S cell cycle control	1/592	61/5488	0.999091306569464	0.999999573275476	0.817968139052016	84699	1
WP4656	Joubert syndrome	1/592	66/5488	0.999490079311863	0.999999573275476	0.817968139052016	6469	1
WP2857	Mesodermal commitment pathway	3/592	112/5488	0.999731959235937	0.999999573275476	0.817968139052016	8553/3624/5915	3
WP179	Cell cycle	3/592	113/5488	0.999757396449342	0.999999573275476	0.817968139052016	994/4616/7043	3
WP138	Androgen receptor signaling pathway	1/592	81/5488	0.999910198393434	0.999999573275476	0.817968139052016	8431	1
WP2446	Retinoblastoma gene in cancer	1/592	86/5488	0.9999497212	0.999999573275476	0.817968139052016	994	1
WP437	EGF/EGFR signaling pathway	4/592	154/5488	0.999975815926966	0.999999573275476	0.817968139052016	9046/7837/9047/6772	4
WP4549	Fragile X syndrome	1/592	93/5488	0.999977699715076	0.999999573275476	0.817968139052016	4318	1
WP411	mRNA processing	1/592	122/5488	0.999999240758532	0.999999573275476	0.817968139052016	10772	1
WP4352	Ciliary landscape	4/592	194/5488	0.999999573275476	0.999999573275476	0.817968139052016	875/30845/3934/2040	4
